← boothcheck

KVUE vs UL stock comparison

Kenvue Inc. vs UNILEVER PLC, two Household Products stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Kenvue sells consumer-health brands like Tylenol and Band-Aid, earning 10.61% margin and 15.29% return on equity at $36.7B. Unilever is a much larger staples house, $132.2B, wider at 19.82% margin. Both are reasonably priced, Kenvue at 22.76 times earnings and Unilever at 12.87, though the giant is cheaper per dollar of profit. Kenvue pays a heftier 4.31% dividend and generates 4.96% free-cash yield against Unilever's 5.7%. Kenvue runs a light 0.15 debt load while Unilever carries none. On book Kenvue trades at 3.46 times. A focused health-brand spinoff beside a diversified global staples name, both delivering dependable cash to holders.

Comparison updated 2026-07-11.

KVUE vs UL: the numbers

MetricKVUEUL
Price$19.46$61.73
Market cap$37.4B$134.8B
SectorHousehold ProductsHousehold Products
StageMatureMature
Implied growth (priced in)-2.2%
P/E23.213.1
P/B3.537.05
P/S2.452.46
EV/EBITDA11.911.6
Revenue growth+0.1%-0.4%
Gross margin58.9%47.0%
Operating margin19.6%17.9%
Net margin10.6%19.8%
Return on equity15.3%56.9%
Return on assets6.0%14.2%
Return on invested capital15.2%36.7%
FCF yield4.9%5.6%
Dividend yield4.2%
Debt / equity0.150.00
Current ratio0.980.79
Altman Z (solvency)2.032.47
Piotroski F (quality)8 / 97 / 9
Full KVUE report → Full UL report →
Get boothcheck's read on KVUE and UL, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.